Australia Imaging Biomarkers Market Size & Outlook

The imaging biomarkers market in Australia is expected to reach a projected revenue of US$ 1,104.9 million by 2033. A compound annual growth rate of 13.3% is expected of Australia imaging biomarkers market from 2025 to 2033.
Revenue, 2024 (US$M)
$372.5
Forecast, 2033 (US$M)
$1,104.9
CAGR, 2025 - 2033
13.3%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia imaging biomarkers market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia imaging biomarkers market highlights

  • The Australia imaging biomarkers market generated a revenue of USD 372.5 million in 2024 and is expected to reach USD 1,104.9 million by 2033.
  • The Australia market is expected to grow at a CAGR of 13.3% from 2025 to 2033.
  • In terms of segment, molecular/nuclear biomarkers was the largest revenue generating biomarkers in 2024.
  • Quantitative Imaging Biomarkers is the most lucrative biomarkers segment registering the fastest growth during the forecast period.


Imaging biomarkers market data book summary

Market revenue in 2024USD 372.5 million
Market revenue in 2033USD 1,104.9 million
Growth rate13.3% (CAGR from 2025 to 2033)
Largest segmentMolecular/nuclear biomarkers
Fastest growing segmentQuantitative Imaging Biomarkers
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAnatomical Biomarkers, Functional Biomarkers, Molecular/Nuclear Biomarkers, Quantitative Imaging Biomarkers


Other key industry trends

  • In terms of revenue, Australia accounted for 2.7% of the global imaging biomarkers market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China imaging biomarkers market is projected to lead the regional market in terms of revenue in 2033.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,826.7 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Imaging Biomarkers Market Companies

Name Profile # Employees HQ Website
F. Hoffmann-La Roche AG View profile - - -
PerkinElmer, Inc. View profile - - -
Bio-Rad Laboratories, Inc. View profile - - -
IXICO PLC View profile 83 15 Long Lane, 4th Floor, Griffin Court, London, United Kingdom, EC1A 9PN https://www.ixico.com
Median Technologies View profile 101-250 Valbonne, Provence-Alpes-Cote d'Azur, France, Europe http://www.mediantechnologies.com
Brainomix View profile 11-50 Oxford, Oxfordshire, United Kingdom, Europe http://www.brainomix.com
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Australia imaging biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to imaging biomarkers market will help companies and investors design strategic landscapes.


Molecular/nuclear biomarkers was the largest segment with a revenue share of 37.61% in 2024. Horizon Databook has segmented the Australia imaging biomarkers market based on anatomical biomarkers, functional biomarkers, molecular/nuclear biomarkers, quantitative imaging biomarkers covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Australia imaging biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia imaging biomarkers market databook

  • Our clientele includes a mix of imaging biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia imaging biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Australia imaging biomarkers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia imaging biomarkers market size, by biomarkers, 2021-2033 (US$M)

Australia Imaging Biomarkers Market Outlook Share, 2024 & 2033 (US$M)

Australia imaging biomarkers market size, by biomarkers, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online